Skip to main content
All lobbying filings

JOHNSON & JOHNSON SERVICES, INC.

Lobbying for JOHNSON & JOHNSON SERVICES INC

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $1,030,000.00 expenses · posted Jul 21, 2025

Official filing document

 Bills named in this filing 14
  • HR 1539
    Medical Device Electronic Labeling Act
  • S 266
    Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
  • HR 946
    ORPHAN Cures Act
  • S 864
    HELP Copays Act
  • HR 2214
    DRUG Act
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • S 832
    EPIC Act of 2025
  • S 1954
    Biosimilar Red Tape Elimination Act
  • HR 2527
    Early Detection of Vision Impairments for Children Act of 2025
  • S 1040
    Drug Competition Enhancement Act
  • S 1041
    Affordable Prescriptions for Patients Act
  • S 1097
    Interagency Patent Coordination and Improvement Act of 2025
  • HR 1109
    Litigation Transparency Act of 2025
  • HRES 1301
    Expressing support for the inaugural Heart Recovery Awareness Day on February 20, 2025.
 Lobbying activity 8
Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954, Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments

Budget/Appropriations

- Issues related to stroke care

Copyright/Patent/Trademark

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions Issues related to - intellectual property, including S. 1040, a bill to amend the Federal Trade Commission Act to prohibit product hopping - Medication Affordability and Patent Integrity Act - patent thickets

Law Enforcement/Crime/Criminal Justice

Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - the Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding

Pharmacy

- Issues related to the SUPPORT Act

Science/Technology

Issues related to - artificial intelligence - data privacy - cybersecurity - robotics

Taxation/Internal Revenue Code

Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in TCJA including in 2025 reconciliation bills

Veterans

- Issues related to Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem